Stocks to Watch on March 17: IndusInd Bank, Infosys, Wipro, Brigade Enterprises and more

Wipro | IT services company announced a realignment of its Global Business Lines (GBLs) to enhance its focus on AI, cloud, and digital transformation while improving alignment with evolving client needs. The restructuring maintains four business lines, each tailored to address distinct client buying behaviors. These changes will come into effect on April 1, 2025.

Brigade Enterprises | Real estate company said it has launched its latest residential project, Brigade Eternia, in Yelahanka, Bengaluru. Spanning 14.65 acres, the project comprises 1,124 residential units with a total built-up area of approximately 2 million square feet across 12 towers of 2 basement + ground + 13/14 floors each. Brigade Eternia has an estimated revenue potential of over ₹2,700 crore and is scheduled for completion by March 31, 2030. Also, the company said it has launched “Ebony at Brigade Orchards,” a premium joint venture residential project in Devanahalli, Bengaluru.

Zydus Lifesciences | Drug maker announced the successful completion of a United States Food and Drug Administration (USFDA) inspection at its API Unit 1 in Ankleshwar, Gujarat. The surveillance inspection, conducted from March 10 to March 14, 2025, concluded without any observations. “We wish to inform that the USFDA conducted a surveillance inspection at the group’s API Unit 1, located at Ankleshwar in Gujarat. The inspection was conducted from March 10th to 14th, 2025. The inspection concluded with NIL observations,” Zydus Lifesciences said.

Shilpa Medicare | Pharmaceutical company said its wholly owned subsidiary Shilpa Pharma Lifesciences Ltd has successfully cleared a US Food and Drug Administration (USFDA) inspection at its Unit-2 facility in Raichur with zero observations. The inspection, conducted from March 10 to March 14, 2025, concluded without any Form 483 being issued. This marks the second consecutive clean inspection at the site.

JB Chemicals | The company announced that its API manufacturing facility (D9) in Panoli, Gujarat, successfully cleared a US Food and Drug Administration (USFDA) inspection without any observations. The inspection, conducted from March 10 to March 13, 2025, concluded with no Form 483 issued. “The company remains committed to producing quality products, embedding a quality culture across the organisation and continuously investing in systems, processes & training of its employees so that it can maintain the highest standards of quality and compliance for all its markets,” it added.

TCS | The country’s largest IT services firm said it has appointed Sudeep Kunnumal as the Chief Human Resources Officer (CHRO) Designate, effective March 14, 2025. He will take over as CHRO upon the superannuation of the incumbent, Milind Lakkad. Kunnumal, who currently leads the Human Resources function for the Banking, Financial Services, and Insurance (BFSI) vertical, has been associated with TCS since 2000. He holds a Master’s degree in Human Resource Management from Madurai Kamaraj University.

Power Grid | State-owned company said it has approved an investment of ₹341.57 crore for two transmission projects. The approvals were granted by the Committee of Directors on Investment on Projects. The first project, “Transmission scheme for evacuation of power from Ratle HEP (850 MW) & Kiru HEP (624 MW): Part B,” has an estimated cost of ₹218.55 crore, with Part I valued at ₹177.38 crore and Part II at ₹41.17 crore. The project is scheduled for commissioning by July 14, 2026.

Alkem Laboratories | Pharmaceutical company announced that the United States Food and Drug Administration (US FDA) conducted a Bioresearch Monitoring (BIMO) inspection at its Bioequivalence Center in Taloja, Maharashtra, from March 10 to March 13, 2025. “This is to inform you that US FDA had conducted a Bioresearch Monitoring (BIMO) inspection at the Company’s Bioequivalence Center located at Taloja, Maharashtra, from 10th March 2025 to 13th March 2025,” Alkem Laboratories said in a regulatory filing.

Ceigall India | Infrastructure company said it has received a Letter of Award (LOA) from the National Highways Authority of India (NHAI) for the development of a six-lane greenfield southern Ludhiana bypass. The project, awarded under the Hybrid Annuity Mode (HAM), is part of the Ludhiana-Ajmer Economic Corridor in Punjab. The contract entails developing a 25.24 km stretch from NH44 near Village Rajgarh to the Delhi-Katra Expressway (NE 5) near Village Ballowal.

Tejas Networks | Telecom gear-maker said it has received ₹123.45 crore from the Ministry of Communications, Department of Telecommunications, as an incentive under the Production Linked Incentive (PLI) Scheme for Telecom and Networking Products for the financial year 2023-24.

GR Infraprojects | Infrastructure company said it has been selected as the winning bidder for the Agra-Gwalior Greenfield Road project, tendered by the National Highways Authority of India (NHAI) under the Ministry of Road Transport & Highways. The project, awarded under the Design, Build, Finance, Operate, and Transfer (DBFOT) model at BOT (Toll) mode, is valued at ₹4,262.78 crore.

Alkem Laboratories | Pharmaceutical company announced that the United States Food and Drug Administration (US FDA) conducted a Bioresearch Monitoring (BIMO) inspection at its Bioequivalence Center in Taloja, Maharashtra, from March 10 to March 13, 2025. The inspection concluded that no Form 483 had been issued.

YES Bank | Private sector lender said it has introduced a Goods and Services Tax (GST) payment facility, further expanding its digital banking services. The initiative, authorised by the Government of India, enables businesses and individuals to make GST payments efficiently through YES BANK’s NetBanking platform and branch network.

NMDC | Navratna PSU has announced that its board of directors will meet on March 17, 2025, to consider an interim dividend for the financial year 2024-25. In line with SEBI’s insider trading regulations, the company has imposed a trading window closure for insiders, designated persons, and their immediate relatives from March 7 to March 19, 2025.

Indian Bank | The bank has informed that its Board of Directors will meet on Thursday, March 20, 2025, to consider a proposal for the bank’s fund-raising plan. The meeting will be held in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Galaxy Surfactants | Speciality chemicals Galaxy Surfactants Ltd on Saturday (March 15) said it has declared an interim dividend of ₹18 per equity share with a face value of ₹10 for the financial year 2024-25. The decision was approved in the company’s Board of Directors meeting held on March 15, 2025. The record date for determining shareholders eligible to receive the dividend has been set as March 20, 2025.

IRFC | Indian Railway Finance Corporation (IRFC) Ltd has scheduled a board meeting on Monday, March 17, 2025, to consider the declaration of a second interim dividend for the financial year 2024-25. The company has also set March 21, 2025, as the record date to determine shareholders eligible for the dividend, subject to the board’s approval.